Retinal imaging technology is rapidly advancing and can provide ever-increasing amounts
of information about the structure, function and molecular composition of retinal tissue in …

Recent developments in imaging technologies now allow the documentation, qualitative and
quantitative evaluation of peripheral retinal lesions. As wide field retinal imaging, capturing …

Background/Aims To develop a convolutional neural network (CNN) to detect symptomatic
Alzheimer's disease (AD) using a combination of multimodal retinal images and patient data …

Alzheimer's disease (AD) is the most prevalent form of dementia, accounting for 60–70% of
all dementias. AD is often under-diagnosed and recognized only at a later, more advanced …

Dementia, including Alzheimer's disease (AD), is a major disorder, leading to several ocular
manifestations amongst the elderly population. These visual disorders may be due to retinal …

Amyloid beta (Aβ) deposits in the retina of the Alzheimer's disease (AD) eye may provide a
useful diagnostic biomarker for AD. This study focused on the relationship of Aβ with …

Ophthalmic biomarkers have long played a critical role in diagnosing and managing ocular
diseases. Oculomics has emerged as a field that utilizes ocular imaging biomarkers to …

Exosomes are a group of vesicles that package and transport DNA, RNA, proteins, and
lipids to recipient cells. They can be derived from blood, saliva, urine, and/or other biological …

Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide which
unfortunately has no known effective cure to date. Despite many clinical trials indicating the …

Given the fact that different types of dementia can be diagnosed only postmortem or when
the disease has progressed enough to cause irreversible damage to certain brain areas …